Tumor Suppressor Genes: Prospects for Cancer Therapies
- 1 February 1995
- journal article
- review article
- Published by Springer Nature in Nature Biotechnology
- Vol. 13 (2) , 127-131
- https://doi.org/10.1038/nbt0295-127
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesisNature, 1992
- Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18Nature, 1991
- Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathwayNature, 1990
- Genetic Analysis of an Inherited Predisposition to Colon Cancer in a Family with a Variable Number of Adenomatous PolypsNew England Journal of Medicine, 1990
- Linkage analysis in familial adenomatous polyposis: Order of C11P11 (D5S71) and ?227 (D5S37) loci at the apc geneGenomics, 1989
- Neurofibromatosis 2New England Journal of Medicine, 1988
- Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinomaNature, 1988
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971